
CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about the product's potential, we spoke with Prof. Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022.
Prof. Dr. Christiane Kuhl, PhD, chair of radiology at University Hospital Aachen.